Related Experiment Videos
Patients' perspectives on nonadherence to statin therapy: a focus-group study
Vicki Fung1, Fiona Sinclair, Huihui Wang
1Division of Research, Oakland, CA, USA. vicki.fung@kp.org
The Permanente Journal
|August 27, 2010
Summary
Patient concerns about statin side effects and a desire for more information significantly impact adherence to cholesterol-lowering medication. Addressing these factors is crucial for improving cardiovascular outcomes.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Patient Adherence Research
Background:
- Nonadherence to statin therapy is a significant issue linked to adverse cardiovascular outcomes.
- Understanding patient perspectives is vital for improving treatment efficacy.
Purpose of the Study:
- To explore the factors and perceptions contributing to nonadherence in statin therapy.
- To identify patient-suggested strategies for enhancing statin adherence.
Main Methods:
- A qualitative study involving three patient focus groups.
- 18 adult patients with new statin prescriptions and documented gaps in supply were enrolled.
- Content analysis of focus group transcripts was performed to identify key themes.
Main Results:
- Key factors for nonadherence included concerns about adverse effects, uncertainty regarding statin benefits, and convenience issues.
- Concerns about adverse effects were a dominant theme among participants.
- Patients desired more information on statin risks/benefits and alternative cholesterol-lowering approaches.
Conclusions:
- Patient concerns about adverse effects and a need for more information are primary drivers for reduced statin use.
- Interventions addressing patient concerns and perceptions are necessary to improve statin therapy adherence.
- Improving adherence to statin therapy can lead to better cardiovascular health outcomes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: